11:50 AM EST - Ceapro Inc. : announced its financial results and operational highlights for the year ended December 31, 2013. Total sales were $6,524,000 compared to $5,165,000 in 2012, an increase of 26.3%. This sales increase is mostly attributed to a 28% increase for flagship product, avenanthramides. Net Profit of $176,000 compared to a net loss of $538,000 in 2012. Ceapro Inc.
shares V.CZO are trading up $0.005 at $0.13.
